Asymmetry Capital Management as of March 31, 2020
Portfolio Holdings for Asymmetry Capital Management
Asymmetry Capital Management holds 29 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arena Pharmaceuticals | 11.5 | $11M | 250k | 42.00 | |
| Rts/bristol-myers Squibb Compa | 9.9 | $9.1M | 2.4M | 3.80 | |
| Baxter International (BAX) | 6.7 | $6.1M | 76k | 81.19 | |
| Guardant Health (GH) | 5.8 | $5.3M | 76k | 69.60 | |
| BioMarin Pharmaceutical (BMRN) | 5.1 | $4.6M | 55k | 84.50 | |
| Ptc Therapeutics I (PTCT) | 4.9 | $4.5M | 101k | 44.61 | |
| Bio-Rad Laboratories (BIO) | 4.9 | $4.4M | 13k | 350.58 | |
| Global Blood Therapeutics In | 4.8 | $4.4M | 87k | 51.09 | |
| UnitedHealth (UNH) | 4.3 | $3.9M | 16k | 249.38 | |
| Twist Bioscience Corp (TWST) | 4.2 | $3.8M | 124k | 30.58 | |
| Myokardia | 3.7 | $3.4M | 73k | 46.88 | |
| Ascendis Pharma A S (ASND) | 3.5 | $3.2M | 28k | 112.62 | |
| Amicus Therapeutics (FOLD) | 3.2 | $2.9M | 318k | 9.24 | |
| Fate Therapeutics (FATE) | 2.9 | $2.7M | 120k | 22.21 | |
| Cytokinetics (CYTK) | 2.6 | $2.4M | 204k | 11.79 | |
| Momenta Pharmaceuticals | 2.5 | $2.3M | 83k | 27.20 | |
| Tandem Diabetes Care (TNDM) | 2.3 | $2.1M | 32k | 64.35 | |
| Varian Medical Systems | 2.0 | $1.8M | 18k | 102.67 | |
| Nanostring Technologies (NSTGQ) | 2.0 | $1.8M | 75k | 24.05 | |
| Marinus Pharmaceuticals | 1.9 | $1.7M | 855k | 2.03 | |
| Uniqure Nv (QURE) | 1.7 | $1.5M | 32k | 47.45 | |
| 10x Genomics Inc Cl A (TXG) | 1.7 | $1.5M | 25k | 62.31 | |
| Sarepta Therapeutics (SRPT) | 1.6 | $1.5M | 15k | 97.83 | |
| Avrobio Ord (AVRO) | 1.5 | $1.3M | 86k | 15.56 | |
| Immunomedics | 1.4 | $1.2M | 92k | 13.48 | |
| Cymabay Therapeutics | 1.2 | $1.1M | 762k | 1.48 | |
| Nucana Plc american depositary shares (NCNA) | 1.2 | $1.1M | 186k | 5.83 | |
| Centene Corporation (CNC) | 1.1 | $969k | 16k | 59.38 | |
| Exicure | 0.2 | $157k | 106k | 1.48 |
